How do Belgian mobile intensive care units deal with cardiovascular emergencies?

European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine
Alex M HeyseP Calle

Abstract

To assess the availability and use of diagnostic tools, therapeutic equipment and drugs for the prehospital treatment of acute coronary syndromes, cardiopulmonary arrest and other cardiovascular emergencies in Belgian physician-staffed and hospital-based mobile intensive care units. In April 2001, a questionnaire was sent to all Belgian mobile intensive care unit centres. The response rate was 90%. There was a 100% availability of many drugs and therapeutic equipment, with a well-established role in the care of cardiovascular emergencies: defibrillators, nitrates, epinephrine, atropine and diuretics. Important emergency drugs and tools were not ubiquitously available: external pacemakers (90%), aspirin (90%), bicarbonate (99%), amiodarone (87%), and intravenous beta-blockers (75%). Twelve-lead electrocardiogram recorders and thrombolytics had a rather low availability (46 and 20%, respectively) and were rarely used. There was a high availability of some drugs with limited data to support their use: oral calcium antagonists (61%), bretylium (65%) and isoproterenol (92%). In Belgian mobile intensive care units the availability and use of technical and diagnostic equipment and cardiac drugs varied to an important extent. A local m...Continue Reading

References

May 1, 1985·Circulation·P M ZollE M Antman
Nov 1, 1993·Annals of Emergency Medicine·M P LarsenA P Hallstrom
Jan 1, 1994·Annals of Emergency Medicine·R WuerzG S Roth
Sep 16, 1999·The New England Journal of Medicine·P J KudenchukT Walsh
Oct 26, 1999·The American Journal of Emergency Medicine·G M PurvisF A Gaffney
Mar 22, 2002·The New England Journal of Medicine·Paul DorianAiala Barr
May 16, 2002·Heart·W W Klein
Jun 6, 2003·European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine·Koen De GraeveWalter A Buylaert

❮ Previous
Next ❯

Citations

Apr 15, 2016·European Journal of Pediatrics·Pierre DemaretAndré Mulder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.